Universities Beg For Cash To Repair Crumbling Labs

WASHINGTON—Everybody seems eager to see a federally sponsored academic research facilities program. But no one seems to know how to fund it. The lack of consensus on how the United States government would finance the rejuvenation of aging university laboratories has led to conflicting advice from traditional allies, mixed signals from the Bush administration, and a scatter-shot approach by Congress. As a result, the chances appear slim that any such program will get off the ground this

| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

WASHINGTON—Everybody seems eager to see a federally sponsored academic research facilities program. But no one seems to know how to fund it. The lack of consensus on how the United States government would finance the rejuvenation of aging university laboratories has led to conflicting advice from traditional allies, mixed signals from the Bush administration, and a scatter-shot approach by Congress. As a result, the chances appear slim that any such program will get off the ground this year.

One major issue is how many programs there should be. Although earlier legislative proposals sought a coordinated effort financed by a tax on the research budgets of various federal agencies, a bill that Congress passed last year set up a program within the National Science Foundation. Naturally, NSF officials interpreted that decision to mean a program to repair and replace facilities only in the fields of science that it supports. A report ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies